FDA’s enforcement discretion allowing to expand remote use of Philips IntelliSite Pathology Solution during COVID-19 emergency
April 2, 2020Intention to exercise enforcement discretion due to COVID-19 emergency by the U.S. Food and Drug Administration (FDA) provides […]